"10.1371_journal.pone.0140074","plos one","2015-10-07T00:00:00Z","Iris Chen; William Clarke; San-San Ou; Mark A Marzinke; Autumn Breaud; Lynda M Emel; Jing Wang; James P Hughes; Paul Richardson; Danielle F Haley; Jonathan Lucas; Anne Rompalo; Jessica E Justman; Sally L Hodder; Susan H Eshleman","Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America; Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America; Science Facilitation Department, FHI 360, Durham, North Carolina, United States of America; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, New York, United States of America; Clinical and Translational Science Institute, West Virginia University, Morgantown, West Virginia, United States of America","Conceived and designed the experiments: SHE. Performed the experiments: AB. Analyzed the data: IC SSO LME JW JPH SHE. Contributed reagents/materials/analysis tools: WC MAM. Wrote the paper: IC SHE. HPTN LC QA/QC Representative for HPTN 064: PR. Senior Clinical Research Manager for HPTN 064: DFH. Community Representative for HPTN 064: JL. Principal Investigator for the HPTN 064 site in Baltimore, Maryland: AR. Protocol Co-Chair for HPTN 064 and Principal Investigator for the HPTN 064 site in Bronx, New York: JEJ. Protocol Chair for HPTN 064 and Principal Investigator for the HPTN 064 site in Newark, New Jersey: SLH.","The authors have declared that no competing interests exist, with the following exceptions: Dr. Clarke receives research support from Thermo Fisher Scientific, including monetary support, instrument placement, and reagents. Dr. Clarke also acts as a consultant for Thermo Fisher Scientific. Dr. Hodder is a consultant for Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, and Viiv Healthcare and has received research support from Gilead Sciences, Janssen Pharmaceuticals, and Viiv Healthcare. Dr. Hodders spouse has ownership interest (stock options) in Merck and Co. The companies mentioned did not have any involvement in this study. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","10","Iris Chen","IC",15,FALSE,1,1,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
